Back To Search Results

Ptosis

Editor: Marco A. Siccardi Updated: 8/8/2023 12:01:14 AM

Introduction

Ptosis is an abnormally low-positioned upper eyelid, also called blepharoptosis, which can decrease or even occlude vision completely. It may be congenital or acquired in origin. Proper management requires recognizing the exact etiology and treating it accordingly, whether surgically or medically, to improve patient outcome.[1]

Etiology

Register For Free And Read The Full Article
Get the answers you need instantly with the StatPearls Clinical Decision Support tool. StatPearls spent the last decade developing the largest and most updated Point-of Care resource ever developed. Earn CME/CE by searching and reading articles.
  • Dropdown arrow Search engine and full access to all medical articles
  • Dropdown arrow 10 free questions in your specialty
  • Dropdown arrow Free CME/CE Activities
  • Dropdown arrow Free daily question in your email
  • Dropdown arrow Save favorite articles to your dashboard
  • Dropdown arrow Emails offering discounts

Learn more about a Subscription to StatPearls Point-of-Care

Etiology

Ptosis is classified into congenital or acquired based on the age of presentation; the latter is usually further categorized into five types based on etiology[2]:

  • Neurogenic: It results from defective innervation of the levator muscle of the upper eyelid. For example, third nerve palsy, Horner syndrome, Marcus Gunn jaw-winking syndrome, multiple sclerosis, etc.
  • Myogenic: Levator muscle myopathy or defect at its neuromuscular junction causes the myogenic ptosis, which includes myasthenia gravis, ocular myopathy, simple congenital blepharophimosis syndrome, etc.
  • Mechanical: Levator function is impaired due to the mass effect of some abnormal external structure such as a neoplasm, chalazion, contact lens in the upper fornix, scarring, etc.
  • Aponeurotic: Also known as Involutional ptosis, it results from a defective levator aponeurosis due to aging, trauma, or postoperative complications.
  • Traumatic: Any direct or indirect trauma to the eyelid, leading to levator transection, cicatrization, eyelid laceration, or orbital rooftop fracture with ischemia, can cause ptosis.

Epidemiology

Among all cases of ptosis, congenital ptosis is the most common type, which seems to be more prevalent in males. Simple congenital ptosis is the most prevalent form of congenital ptosis.[3] Among acquired cases, aponeurotic ptosis is the most common type, which usually presents in late adulthood.[4] Not enough data is available yet about the incidence of ptosis.[5] However, the prevalence of ptosis does not seem to be affected by other epidemiological factors such as race, etc.

Pathophysiology

Levator palpebrae superioris (LPS) and Muller's muscle are two muscles of the upper eyelid responsible for its elevation. LPS is the main elevator, which is supplied by the oculomotor nerve. The levator palpebrae superioris muscle originates from the lesser wing of the sphenoid bone, and it travels anteriorly above the superior rectus muscle. It attaches in multiple insertions: anteriorly into the upper eyelid skin, inferiorly on the anterior surface of the upper tarsal plate, and to the superior conjunctival fornix. Muller's muscle is a smooth muscle also attached to the superior tarsal plate with sympathetic innervation, which is defective in ptosis of Horner syndrome.[1] Loss of innervation of LPS and Müller's muscle causes neurogenic ptosis.

Levator muscle dystrophy causes simple congenital ptosis. On the other hand, involutional changes in the eyelid are the most common pathogenesis in adult ptosis. Decreasing tone and thinning of the levator muscle, due to aging, result in an abnormal position of the eyelid. Disinsertion of the levator aponeurosis, or its dehiscence, after any trauma or surgery, can also lead to ptosis.[5]

History and Physical

Presentation:

The main presenting complaint of patients with ptosis is the visual disturbance, ranging from mild to severe, which can be unilateral or bilateral, along with cosmetic disfigurement. Ptosis may be accompanied by some other problems depending upon the etiology.

History:

Age of onset and duration of symptoms are important to differentiate congenital from acquired cases. There may also be other symptoms of associated etiologies, such as diurnal variability, diplopia, eyeball deviation, body fatigability, etc. The patient should be asked about any previous history of trauma, surgery, or medical treatment.[6]

Clinical Evaluation

In the case of ptosis, the upper lid margin covers more than 2 mm of the cornea, making the palpebral fissure narrower than usual. The examiner should observe both eyes and the general appearance of the patient. Backward tilted head, wrinkled skin of the forehead, and elevated eyebrows may present as compensatory changes.[2] Any scar, swelling, or abnormal structure near the eyelids should not be missed. It may present with eyeball deviation, shrinking, or bulging. The following clinical signs should also be examined:

  1. The absence of an upper lid crease signifies congenital ptosis.
  2. Pupillary function, ie, anisocoria in Horner syndrome (miosis) and CN III palsy (mydriasis).[7]
  3. Ocular motility to assess CN III paresis.
  4. Jaw-winking sign to rule out Marcus Gunn jaw-winking syndrome.
  5. Bell's palsy and tear film are checked preoperatively to assess fitness for ptosis surgery.[2][8]
  6. The phenylephrine test is used to assess the Muller's muscle before conjunctival resection. Topical phenylephrine (alpha-adrenergic sympathomimetic) is administered in the superior fornix, and eyelid elevation in response shows ideal candidacy for this surgery.[1]

Myasthenia gravis can manifest as generalized or solely ocular disease with pupil-sparing ptosis. It can be assessed by the edrophonium test, which contains edrophonium, a short-acting acetylcholinesterase inhibitor. A positive test is the eyelid elevation in 2 to 5 minutes after administration of edrophonium.[9] It has relatively low sensitivity, and the ice test has superseded it, in which an ice pack is placed over the ptotic lid for 2 to 5 minutes, and then improvement is noticed.[10]

Evaluation

Proper diagnosis and management of blepharoptosis require assessment by the following measurements:

  1. Levator muscle function: Assessment of the functional status of the levator muscle is by placing the thumb firmly against the patient’s eyebrow, with eyes in a downward gaze. Then the patient looks upward, and the amount of excursion is measured with a scale which can be graded as usual (15 mm), excellent (over 12 mm), good (9 to 11 mm), fair (5 to 9 mm), or poor (less than 4 mm).[11] This test is very important in determining the surgical procedure of choice for ptosis correction.
  2. Margin-reflex distance: Patient fixates on the torchlight held by the examiner, and the distance between the corneal reflection and the upper lid margin is measured. A value of 4 to 5 mm is normal MRD.
  3. Palpebral fissure height: Normally, the upper lid margin covers 2mm, and the lower lid margin covers 1mm of the cornea. The distance between the two is measured in the pupillary plane; 7 to 10 mm in males and 8 to 12 mm in females is normal. Comparing it with the contralateral side and calculating the difference is used to quantify the unilateral ptosis as mild (1 to 2 mm), moderate (3 to 4 mm), or severe (4 mm or more).[2]
  4. Margin crease distance: MCD is the distance between the lid margin and the skinfold of the upper lid measured in downward gaze. Normal values are 7 to 8 mm in males and 8 to 10 mm in females. It is higher than usual in aponeurotic ptosis, whereas it is absent or vague in congenital ptosis.[1]

If myasthenia gravis is suspected, blood serum is tested for acetylcholine receptor antibodies, which are responsible for this autoimmune disorder. However, these are positive only in 50% of patients with solely ocular myasthenia.[9] Antistriated muscle antibodies and muscle-specific tyrosine kinase levels are also checked when myasthenia is highly suspected.

Thyroid studies are not usually needed, but myasthenia often correlates with thyroid disorders, and rarely, ptosis may present in hypothyroidism.[12] Thus, whenever thyroid involvement is suspected, thyroid function must be assessed.

Imaging studies such as X-ray or brain and orbit CT/MRI scans are needed by ophthalmologists and neurologists when any pathology is suspected in these regions, such as a tumor in the orbit or skull, nerve defects, multiple sclerosis, trauma, etc. Thorax radiography is used to assess the thymus in cases of myasthenia.

Treatment / Management

Treatment of ptosis depends upon the underlying etiology, the degree of ptosis, and the function of the levator muscle. In mechanical ptosis, removal of the abnormal structure, i.e., a chalazion, is all that is needed. However, surgical correction is the mainstay of treatment, as well as some nonsurgical options available for specific conditions.

  • Surgical treatment: Surgery is necessary for congenital ptosis and all other types when nonsurgical treatment is not beneficial: the underlying cause and preoperative evaluation of ptosis help in determining the procedure of choice.
    • Levator resection: The Levator muscle is shortened by resecting the muscle if it is not entirely paralyzed with mild (2 mm) to moderate (3 to 4 mm) ptosis.[13] There are different approaches for this purpose:
      • Everbursch: Approach through the skin.
      • Blaskovics: Approach through the palpebral conjunctiva.
      • Fasanella-Servat: A portion of the tarsal plate, palpebral conjunctiva, and Müller's muscle gets excised along with levator resection. It is usually a proposed option in minimal ptosis.[2]
    • Motais' procedure: The Action of the superior rectus is utilized to elevate the lid if the levator muscle is paralyzed.
    • Hess's procedure: Frontalis muscle is used to raise the lid if both the superior rectus and the levator muscle are paralyzed.
    • Frontalis brow suspension: Eyelid is tethered with the frontalis muscle by either fascia tunica obtained from fascia lata or some other suitable synthetic material such as mersiline mesh. It is indicated in severe (over 4 mm) ptosis with poor levator function, especially in the case of congenital ptosis.[14]
    • Aponeurotic strengthening: It involves the advancement of aponeurosis, mostly indicated in aponeurotic disinsertion or involutional ptosis.[13]
  • Nonsurgical treatment: It is indicated in myogenic and some cases of neurogenic ptosis, mostly. For example, taping the upper lid open and spectacle props (eyelid crutches attached to glasses).
  • (B3)

Differential Diagnosis

Pseudoptosis is the false perception of ptosis, which may result from the following[1][2][6]:

  • Contralateral retracted lid
  • Downward deviated ipsilateral eyeball followed by the upper lid
  • Overhanging skin over the upper lid
  • Brow ptosis
  • Upper lid swelling, i.e., preseptal cellulitis, orbital cellulitis, chalazion, etc.
  • Volume deficit as seen in microphthalmos, phthisis bulbi, enophthalmos, etc.

Prognosis

Prognosis depends upon the type and treatment of ptosis. The appropriate surgical procedure applied according to the preoperative evaluation shows a very good prognosis. For example, ptosis with poor levator function corrected with the levator resection instead of the fascia lata sling procedure will show poor results. Proper preoperative assessment and postoperative care with close monitoring fairly improve the outcome of surgical repair in any form of ptosis.

Complications

Complications that can occur after ptosis repair can be subdivided into:

  • Early complications: Postoperative asymmetry in eyelid height and shape is the most common complication.[15] Undercorrection or overcorrection commonly appears postoperatively, which may resolve with time. Surgical site infection and bleeding from the wound are acute but uncommon complications followed by exposure keratopathy, which requires proper monitoring. Postoperative mild lagophthalmos or incomplete closure of the palpebral fissure is common, which usually resolves within 2 to 3 weeks.[2]
  • Late complications: Persistent lagophthalmos, exposure keratopathy, and recurrent ptosis are chronic complications of ptosis repair surgery. Persistent undercorrection or overcorrection requires revision surgery.[1]

Deterrence and Patient Education

Patient education regarding the cause of ptosis and the long-term complications it can cause if untreated is necessary. All treatment options, surgical and nonsurgical, including the best one according to assessment, should be discussed. The clinician must explain to the patient the likely postoperative complications that can occur earlier or later on and their management.

Enhancing Healthcare Team Outcomes

Ptosis is one of the most commonly presenting cases in ophthalmology clinics, which requires management with coordination between the ophthalmologist, optician, nurse, and surgeon for proper management. The majority of patients with ptosis first present in primary care clinics, and it is important to refer these patients to a neurologist and/or ophthalmologist for further workup.

This teamwork is vital for the preoperative assessment and choosing the best treatment option for a particular case of ptosis. Surgical correction of ptosis should be carried out by an oculoplastic surgeon along with a plastic surgeon for the best visual as well as the cosmetic outcome. Specialty-trained nursing will prep the patient, assist during the surgery, and provide post-surgical care and counsel to the patient and/or family, reporting any concerns to the surgeon or other physicians managing the case. Knowledge and evaluation of the case are crucial for the surgeons to perform a procedure in the best interest of the patient. This type of interprofessional collaboration is vital to achieving optimal patient outcomes in ptosis cases.

Media


(Click Image to Enlarge)
Patient with levator function less than 4 mm bilaterally with a preoperative chin-up position and severe ptosis
Patient with levator function less than 4 mm bilaterally with a preoperative chin-up position and severe ptosis. Bilateral frontalis slings (using polytetrafluoroethylene this child) performed to lift the upper eyelids utilizing the brows. Contributed by Prof. BCK Patel MD, FRCS

References


[1]

Koka K, Patel BC. Ptosis Correction. StatPearls. 2025 Jan:():     [PubMed PMID: 30969650]


[2]

Finsterer J. Ptosis: causes, presentation, and management. Aesthetic plastic surgery. 2003 May-Jun:27(3):193-204     [PubMed PMID: 12925861]


[3]

Griepentrog GJ, Diehl NN, Mohney BG. Incidence and demographics of childhood ptosis. Ophthalmology. 2011 Jun:118(6):1180-3. doi: 10.1016/j.ophtha.2010.10.026. Epub 2011 Apr 15     [PubMed PMID: 21496927]

Level 2 (mid-level) evidence

[4]

Lee YG, Son BJ, Lee KH, Lee SY, Kim CY. Clinical and Demographic Characteristics of Blepharoptosis in Korea: A 24-year Experience including 2,328 Patients. Korean journal of ophthalmology : KJO. 2018 Aug:32(4):249-256. doi: 10.3341/kjo.2017.0118. Epub     [PubMed PMID: 30091302]


[5]

Damasceno RW, Avgitidou G, Belfort R Jr, Dantas PE, Holbach LM, Heindl LM. Eyelid aging: pathophysiology and clinical management. Arquivos brasileiros de oftalmologia. 2015 Sep-Oct:78(5):328-31. doi: 10.5935/0004-2749.20150087. Epub     [PubMed PMID: 26466237]


[6]

Yadegari S. Approach to a patient with blepharoptosis. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2016 Oct:37(10):1589-96. doi: 10.1007/s10072-016-2633-7. Epub 2016 Jun 21     [PubMed PMID: 27329276]


[7]

Ahmadi AJ, Sires BS. Ptosis in infants and children. International ophthalmology clinics. 2002 Spring:42(2):15-29     [PubMed PMID: 11914701]


[8]

Wong VA, Beckingsale PS, Oley CA, Sullivan TJ. Management of myogenic ptosis. Ophthalmology. 2002 May:109(5):1023-31     [PubMed PMID: 11986113]

Level 2 (mid-level) evidence

[9]

Stojkovic T, Béhin A. [Ocular myasthenia: diagnosis and treatment]. Revue neurologique. 2010 Dec:166(12):987-97. doi: 10.1016/j.neurol.2010.08.004. Epub 2010 Nov 13     [PubMed PMID: 21075410]


[10]

Elrod RD, Weinberg DA. Ocular myasthenia gravis. Ophthalmology clinics of North America. 2004 Sep:17(3):275-309; v     [PubMed PMID: 15337189]


[11]

Anderson RL, Dixon RS. Aponeurotic ptosis surgery. Archives of ophthalmology (Chicago, Ill. : 1960). 1979 Jun:97(6):1123-8     [PubMed PMID: 375893]

Level 3 (low-level) evidence

[12]

Lin YP, Iqbal U, Nguyen PA, Islam MM, Atique S, Jian WS, Li YJ, Huang CL, Hsu CH. The Concomitant Association of Thyroid Disorders and Myasthenia Gravis. Translational neuroscience. 2017:8():27-30. doi: 10.1515/tnsci-2017-0006. Epub 2017 Apr 30     [PubMed PMID: 28729915]


[13]

Hejsek H, Veliká V, Stepanov A, Rozsíval P. [Surgical treatment of severe degree of ptosis of the upper eyelid using a Fronto-tarsal sling of biocompatible PVC]. Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti. 2014 Jun:70(3):103-8     [PubMed PMID: 25032796]

Level 3 (low-level) evidence

[14]

Marenco M, Macchi I, Macchi I, Galassi E, Massaro-Giordano M, Lambiase A. Clinical presentation and management of congenital ptosis. Clinical ophthalmology (Auckland, N.Z.). 2017:11():453-463. doi: 10.2147/OPTH.S111118. Epub 2017 Feb 27     [PubMed PMID: 28280295]


[15]

Kwitko GM, Patel BC. Blepharoplasty Ptosis Surgery. StatPearls. 2025 Jan:():     [PubMed PMID: 29493921]